Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

Market Cap	4.26B
Revenue (ttm)	7.97B
Net Income (ttm)	20.62M
Shares Out	1.50B
EPS (ttm)	0.01
PE Ratio	208.03
Forward PE	n/a
Dividend	0.01 (0.49%)
Ex-Dividend Date	Nov 29, 2024

Volume	21,692,777
Average Volume	33,599,325
Open	2.890
Previous Close	2.850
Day's Range	2.840 - 2.890
52-Week Range	2.070 - 3.670
Beta	0.40
RSI	47.49
Earnings Date	Apr 24, 2025

About SHE:002589

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. The company operates in Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine segments. It sells drugs and medical devices. The company also provides medical logistics services; third-party logistics services; health service platform; and disinfection and sterilization. The company was formerly known as Realcan Pharmaceutical...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 3,239
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002589

Financial Performance

In 2024, SHE:002589's revenue was 7.97 billion, a decrease of -0.85% compared to the previous year's 8.03 billion. Earnings were 20.62 million, an increase of 1.50%.